Agilent Technologies (A)

$146.36 -0.38 (-0.26%)
Market Cap 41.60B
Revenue (ttm) 6.51B
Net Income (ttm) 1.29B
EPS (ttm) N/A
PE Ratio 27.06
Forward PE 24.67
Profit Margin 19.80%
Debt to Equity Ratio 0.53
Volume 1,152,164
Avg Vol 1,728,078
Day's Range N/A - N/A
Shares Out 283.50M
Stochastic %K 70%
Beta 1.29
Analysts Strong Sell
Price Target $151.92

Company Profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems;...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 800 227 9770
Fax: 866 497 1134
Address:
5301 Stevens Creek Boulevard, Santa Clara, United States
rottieluvr3
rottieluvr3 Nov. 10 at 8:15 PM
$A It’s nearing resistance. Watch for a breakout to the upside.
0 · Reply
Uphighup
Uphighup Nov. 5 at 5:36 PM
$PSNY your shares will be worth $$$A lot more if you hold💪
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 5 at 3:11 PM
$A $AAON $AAPL $AB $ABBV 🔥
0 · Reply
Estimize
Estimize Nov. 4 at 2:24 PM
Wall St is expecting 1.58 EPS for $A Q4 [Reporting 11/24 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 2 at 5:22 PM
$A $ACN $TVRD $ABBV $ABM 🔥 CYCLE TRADING SIGNAL PLUGGED INTO AI 🔥 LISTS 🔥 Nothing More Accurate 🔥
0 · Reply
__SquuezedChronometer_
__SquuezedChronometer_ Nov. 2 at 11:23 AM
Next major retail squeeze candidate right here $MCK $NMRA $TD $A >
0 · Reply
WhyNotBe
WhyNotBe Oct. 30 at 11:07 PM
$A lot of insiders and executives that do better with lower prices. My guess, big movement up after earnings and options at low prices for the insiders, just a guess. Nothing but good news and bad stock performance
0 · Reply
Estimize
Estimize Oct. 28 at 2:18 PM
Wall St is expecting 1.58 EPS for $A Q4 [Reporting 12/01 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=
0 · Reply
ST3WPIDHO3
ST3WPIDHO3 Oct. 28 at 1:30 PM
$ASST $GPUS $A
0 · Reply
RunnerSignals
RunnerSignals Oct. 25 at 7:40 PM
$A steady as ever! 10-year winners keep winning. Momentum’s hot but RSI’s flashing "easy there" Still our long-term champs https://stocksrunner.com/symbol/a
0 · Reply
Latest News on A
Agilent to Announce Fourth-Quarter Fiscal Year 2025 Financial Results on Nov. 24

Oct 30, 2025, 4:15 PM EDT - 11 days ago

Agilent to Announce Fourth-Quarter Fiscal Year 2025 Financial Results on Nov. 24

Agilent Names Adam S. Elinoff as Chief Financial Officer

Oct 27, 2025, 4:15 PM EDT - 14 days ago

Agilent Names Adam S. Elinoff as Chief Financial Officer

Agilent Announces New Insight Series Alarm Resolution Systems for Airport Security Screening

Sep 30, 2025, 8:00 AM EDT - 5 weeks ago

Agilent Announces New Insight Series Alarm Resolution Systems for Airport Security Screening

Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing

Sep 29, 2025, 8:00 AM EDT - 6 weeks ago

Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing

Agilent Technologies, Inc. (A) gilent Technologies, Inc. Presents at Bank of merica Global Healthcare Conference 2025 Transcript

Sep 25, 2025, 10:57 AM EDT - 6 weeks ago

Agilent Technologies, Inc. (A) gilent Technologies, Inc. Presents at Bank of merica Global Healthcare Conference 2025 Transcript

Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine

Sep 22, 2025, 9:00 AM EDT - 7 weeks ago

Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine

Agilent Announces Cash Dividend of 24.8 Cents per Share

Sep 17, 2025, 4:05 PM EDT - 7 weeks ago

Agilent Announces Cash Dividend of 24.8 Cents per Share

Agilent to Participate in 2025 Bank of America Global Healthcare Conference

Sep 11, 2025, 4:15 PM EDT - 2 months ago

Agilent to Participate in 2025 Bank of America Global Healthcare Conference

Agilent Refurbishment Centers Achieve Top-Level My Green Lab Certification

Sep 9, 2025, 8:00 AM EDT - 2 months ago

Agilent Refurbishment Centers Achieve Top-Level My Green Lab Certification

Agilent (A) CEO on PFAS Testing Growth & Creating Advanced Instruments for Science

Sep 8, 2025, 4:30 PM EDT - 2 months ago

Agilent (A) CEO on PFAS Testing Growth & Creating Advanced Instruments for Science

Agilent Technologies, Inc. (A) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 3, 2025, 5:28 PM EDT - 2 months ago

Agilent Technologies, Inc. (A) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025

Sep 3, 2025, 8:00 AM EDT - 2 months ago

Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025

Agilent's MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer

Sep 2, 2025, 8:00 AM EDT - 2 months ago

Agilent's MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer

Agilent: Growth Across All Segments, But Investors Will Need To Be Patient

Aug 28, 2025, 8:34 AM EDT - 2 months ago

Agilent: Growth Across All Segments, But Investors Will Need To Be Patient

Agilent Technologies, Inc. (A) Q3 2025 Earnings Call Transcript

Aug 27, 2025, 8:00 PM EDT - 2 months ago

Agilent Technologies, Inc. (A) Q3 2025 Earnings Call Transcript

Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results

Aug 27, 2025, 4:05 PM EDT - 2 months ago

Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results

Life sciences firm Agilent raises annual revenue outlook

Aug 27, 2025, 4:03 PM EDT - 2 months ago

Life sciences firm Agilent raises annual revenue outlook

Agilent to Participate in 2025 Wells Fargo Healthcare Conference

Aug 21, 2025, 4:15 PM EDT - 2 months ago

Agilent to Participate in 2025 Wells Fargo Healthcare Conference

Agilent MMR IHC Panel pharmDx (Dako Omnis) Receives FDA Approval as a Companion Diagnostic Test for Colorectal Cancer

Aug 20, 2025, 8:00 AM EDT - 2 months ago

Agilent MMR IHC Panel pharmDx (Dako Omnis) Receives FDA Approval as a Companion Diagnostic Test for Colorectal Cancer

Shane Snyder to Lead New Agilent Center of Excellence at Georgia Tech Focused on Water and the Environment

Aug 13, 2025, 8:00 AM EDT - 3 months ago

Shane Snyder to Lead New Agilent Center of Excellence at Georgia Tech Focused on Water and the Environment

Agilent Expands the Dako Omnis Family with Three New Models to Meet Evolving Pathology Lab Needs

Aug 4, 2025, 8:00 AM EDT - 3 months ago

Agilent Expands the Dako Omnis Family with Three New Models to Meet Evolving Pathology Lab Needs

Monthly Pay Dividends, From 83 Equities, 80 Funds, And 28 Ideal 'Safer' Dogs For August

Aug 1, 2025, 8:01 AM EDT - 3 months ago

Monthly Pay Dividends, From 83 Equities, 80 Funds, And 28 Ideal 'Safer' Dogs For August

AGNC APLE

Agilent Tech looks to double investments in India, eyes high-teen growth, CEO says

Jul 29, 2025, 9:10 AM EDT - 3 months ago

Agilent Tech looks to double investments in India, eyes high-teen growth, CEO says

Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27

Jul 17, 2025, 4:30 PM EDT - 4 months ago

Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27

Agilent Announces CFO Transition

Jul 15, 2025, 8:30 AM EDT - 4 months ago

Agilent Announces CFO Transition

Agilent to Showcase New Products and Innovations at HPLC 2025

Jun 12, 2025, 8:00 AM EDT - 5 months ago

Agilent to Showcase New Products and Innovations at HPLC 2025

Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)

Jun 4, 2025, 12:17 PM EDT - 5 months ago

Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)

Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript

May 28, 2025, 6:38 PM EDT - 5 months ago

Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript

Life sciences firm Agilent beats quarterly estimates on instrument demand

May 28, 2025, 4:58 PM EDT - 5 months ago

Life sciences firm Agilent beats quarterly estimates on instrument demand

Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results

May 28, 2025, 4:05 PM EDT - 5 months ago

Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results

Agilent Names August Specht as Chief Technology Officer

May 28, 2025, 8:30 AM EDT - 5 months ago

Agilent Names August Specht as Chief Technology Officer

Agilent Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance

May 27, 2025, 8:01 AM EDT - 5 months ago

Agilent Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

May 27, 2025, 8:00 AM EDT - 5 months ago

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

Pascal Soriot and Judy Gawlik Brown Named to Agilent Board of Directors

May 21, 2025, 8:30 AM EDT - 6 months ago

Pascal Soriot and Judy Gawlik Brown Named to Agilent Board of Directors

Agilent Announces My Green Lab Ecolabel 2.0 for the New Infinity III LC Series

May 20, 2025, 8:00 AM EDT - 6 months ago

Agilent Announces My Green Lab Ecolabel 2.0 for the New Infinity III LC Series

Agilent to Participate in Jefferies Global Healthcare Conference

May 15, 2025, 4:14 PM EDT - 6 months ago

Agilent to Participate in Jefferies Global Healthcare Conference

Scale Has Its Advantages: 3 A-Rated REIT Monopolies

May 10, 2025, 7:00 AM EDT - 6 months ago

Scale Has Its Advantages: 3 A-Rated REIT Monopolies

AMT DLR EXR MAA O PLD PSA

Agilent Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research

May 1, 2025, 8:00 AM EDT - 6 months ago

Agilent Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto

Apr 24, 2025, 9:52 AM EDT - 7 months ago

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto

CIO

Smackover Lithium's South West Arkansas Project Receives Unanimous Vote of Approval to Establish the Phase I Brine Production Unit from the Arkansas Oil and Gas Commission

Apr 24, 2025, 8:30 AM EDT - 7 months ago

Smackover Lithium's South West Arkansas Project Receives Unanimous Vote of Approval to Establish the Phase I Brine Production Unit from the Arkansas Oil and Gas Commission

Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025

Apr 24, 2025, 8:00 AM EDT - 7 months ago

Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Apr 17, 2025, 8:00 AM EDT - 7 months ago

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today

Apr 3, 2025, 7:00 AM EDT - 7 months ago

Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today

CSX JBHT NKE OMC PPG TGT

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

Mar 24, 2025, 8:00 AM EDT - 8 months ago

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025

Mar 20, 2025, 1:37 PM EDT - 8 months ago

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025

Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025

Mar 20, 2025, 8:00 AM EDT - 8 months ago

Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025

Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski

Mar 19, 2025, 8:00 AM EDT - 8 months ago

Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications

Mar 10, 2025, 8:19 AM EDT - 8 months ago

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications

Agilent Technologies, Inc. (A) TD Cowen 45th Annual Healthcare Conference (Transcript)

Mar 4, 2025, 3:55 PM EST - 8 months ago

Agilent Technologies, Inc. (A) TD Cowen 45th Annual Healthcare Conference (Transcript)

Agilent Technologies: Recent Price Weakness Makes This Stock A Buy

Mar 1, 2025, 2:04 AM EST - 9 months ago

Agilent Technologies: Recent Price Weakness Makes This Stock A Buy

rottieluvr3
rottieluvr3 Nov. 10 at 8:15 PM
$A It’s nearing resistance. Watch for a breakout to the upside.
0 · Reply
Uphighup
Uphighup Nov. 5 at 5:36 PM
$PSNY your shares will be worth $$$A lot more if you hold💪
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 5 at 3:11 PM
$A $AAON $AAPL $AB $ABBV 🔥
0 · Reply
Estimize
Estimize Nov. 4 at 2:24 PM
Wall St is expecting 1.58 EPS for $A Q4 [Reporting 11/24 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 2 at 5:22 PM
$A $ACN $TVRD $ABBV $ABM 🔥 CYCLE TRADING SIGNAL PLUGGED INTO AI 🔥 LISTS 🔥 Nothing More Accurate 🔥
0 · Reply
__SquuezedChronometer_
__SquuezedChronometer_ Nov. 2 at 11:23 AM
Next major retail squeeze candidate right here $MCK $NMRA $TD $A >
0 · Reply
WhyNotBe
WhyNotBe Oct. 30 at 11:07 PM
$A lot of insiders and executives that do better with lower prices. My guess, big movement up after earnings and options at low prices for the insiders, just a guess. Nothing but good news and bad stock performance
0 · Reply
Estimize
Estimize Oct. 28 at 2:18 PM
Wall St is expecting 1.58 EPS for $A Q4 [Reporting 12/01 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=
0 · Reply
ST3WPIDHO3
ST3WPIDHO3 Oct. 28 at 1:30 PM
$ASST $GPUS $A
0 · Reply
RunnerSignals
RunnerSignals Oct. 25 at 7:40 PM
$A steady as ever! 10-year winners keep winning. Momentum’s hot but RSI’s flashing "easy there" Still our long-term champs https://stocksrunner.com/symbol/a
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 9:38 PM
$A $AAAU $AAOI $AAPB $AAPU 10/10 to 10/24 List Results 🔥 Cycle Trading Signal plugged into AI 🔥
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 7:46 AM
Enter: $A NOV 21 2025 $150 CALLS Buy in Price: $3.40 - $3.70 Take Profit: $6.94 Stop Bleeding: $2.99 ROI Potential: 104% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
anvesti
anvesti Oct. 22 at 2:43 AM
$BYND $MLAB $A
0 · Reply
Estimize
Estimize Oct. 21 at 2:39 PM
Wall St is expecting 1.58 EPS for $A Q4 [Reporting 12/01 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=
0 · Reply
stocktrade110
stocktrade110 Oct. 20 at 3:40 PM
$DVLT Great holding for long term. It will reach $5 sooner than I expect!! $A $PATH $ARAI $NVTS
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 6:04 AM
Enter: $A NOV 21 2025 $145 CALLS Buy in Price: $4.40 - $5.00 Take Profit: $10.52 Stop Bleeding: $3.87 ROI Potential: 139% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 19 at 4:57 AM
Enter: $A NOV 21 2025 $145 CALLS Buy in Price: $4.40 - $5.00 Take Profit: $5.59 Stop Bleeding: $3.87 ROI Potential: 27% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 18 at 9:27 AM
Enter: $A NOV 21 2025 $145 CALLS Buy in Price: $4.49 - $4.60 Take Profit: $10.46 Stop Bleeding: $3.95 ROI Potential: 133% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
patten1962
patten1962 Oct. 17 at 1:48 PM
$PACB What if $TXG is really wanting to buy @PacBio ? All along i thought it might be $A , or $TMO Maybe even Softbank But 10 X Genomics is logical!
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 16 at 5:16 PM
Enter: $A NOV 21 2025 $140 CALLS Buy in Price: $5.10 - $6.70 Take Profit: $9.33 Stop Bleeding: $4.49 ROI Potential: 83% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 15 at 6:31 PM
$A Share Price: $139.37 Contract Selected: Jan 16, 2026 $140 Calls Buy Zone: $7.14 – $8.82 Target Zone: $11.65 – $14.24 Potential Upside: 54% ROI Time to Expiration: 92 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply